芦丁在BV2细胞中抗弓形虫的作用及机制分析

doi:10.11843/j.issn.0366-6964.2024.07.030

畜牧兽医学报 ›› 2024, Vol. 55 ›› Issue (7): 3119-3131.doi: 10.11843/j.issn.0366-6964.2024.07.030

芦丁在BV2细胞中抗弓形虫的作用及机制分析

韩成全¹(), 刘婧陶², 于淼³, 关立增¹, 徐璐¹^,*(), 王悦尚⁴^,*()

1. 临沂大学农林科学学院，临沂 276000
2. 齐齐哈尔市龙沙区农业综合服务中心，齐齐哈尔 161000
3. 上海美迪西生物医药股份有限公司病理研究部，上海 200000
4. 临沂大学医学院，临沂 276000

收稿日期:2023-07-30 出版日期:2024-07-23 发布日期:2024-07-26
通讯作者: 徐璐,王悦尚 E-mail:hcq2012a@163.com;xulu0824@126.com;wyueshang@hotmail.com
作者简介:韩成全(1987-)，男，山东临沂人，博士，讲师，主要从事弓形虫致病机制及抗弓形虫药物筛选、动物健康养殖研究，E-mail: hcq2012a@163.com，Tel：+86 0539-7258720
基金资助:
国家自然科学基金(31660614);大学生创新创业训练计划项目(X202210452489)

Study on the Anti-Toxoplasma gondii Effect of Rutin in BV2 Cells and Its Mechanism

Chengquan HAN¹(), Jingtao LIU², Miao YU³, Lizeng GUAN¹, Lu XU¹^,*(), Yueshang WANG⁴^,*()

1. College of Agriculture and Forestry Science, Linyi University, Linyi 276000, China
2. Agricultural Comprehensive Service Center, Longsha District, Qiqihar City, Qiqihar 161000, China
3. Pathology Research Department, Shanghai Medicilon Biomedical Incorporated Company, Shanghai 200000, China
4. College of Medicine, Linyi University, Linyi 276000, China

Received:2023-07-30 Online:2024-07-23 Published:2024-07-26
Contact: Lu XU, Yueshang WANG E-mail:hcq2012a@163.com;xulu0824@126.com;wyueshang@hotmail.com

摘要/Abstract

摘要：

本研究旨在分析芦丁在BV2细胞中的体外抗弓形虫作用及其潜在机制。首先通过CCK8法、间接荧光染色法等测定芦丁的细胞毒性、弓形虫抑制率及增殖情况以探究芦丁在BV2细胞中的抗弓形虫作用；随后，将细胞分成4组，分别为：空白组(Normal)、感染对照组(T. gondii)、感染后低剂量芦丁治疗组(Rut 50)和感染后高剂量芦丁治疗组(Rut 100)，进行弓形虫感染及芦丁处理试验，并用ELISA等方法检测细胞培养液上清液中抗氧化酶SOD、GSH及脂质氧化产物MDA水平，炎症因子TNF-α、IL-6及IL-1β水平，用Western blot检测BV2细胞中PI3K/AKT/Nrf2/HO-1、TLR4/NF-κB及P2X7R/NLRP3信号通路中关键蛋白表达量。结果表明，在BV2细胞中，50和100 μg·mL^－1的芦丁具有明显的抗虫效果，可显著抑制弓形虫感染率、入侵能力和增殖(P < 0.05)。50和100 μg·mL^－1的芦丁还可显著增多上清液中的SOD、GSH含量并降低MDA含量(P < 0.05)，且降低TNF-α、IL-6及IL-1β水平(P < 0.05)，并显著上调抗氧化通路PI3K/AKT/Nrf2/HO-1、下调炎症通路TLR4/NF-κB及P2X7R/NLRP3中关键蛋白表达量(P < 0.05)。结果提示，芦丁在BV2细胞中具有明显的抗弓形虫作用，这可能与其可以通过激活PI3K/AKT/Nrf2/HO-1通路从而增强细胞抗氧化能力、以及抑制TLR4/NF-κB及P2X7R/NLRP3通路从而减弱炎症反应有关。研究结果可为后续探究芦丁体内抗虫效果及分析其对弓形虫性脑损伤保护机制相关研究提供一定的理论参考，并为将芦丁开发成治疗人畜弓形虫病的潜在药物提供科学依据。

关键词: 芦丁, 抗弓形虫作用, BV2细胞, 抗氧化, 抗炎, PI3K/AKT/Nrf2/HO-1, TLR4/NF-κB, P2X7R/NLRP3

Abstract:

This experiment was conducted to study the in vitro anti-Toxoplasma gondii (T. gondii) effect of rutin and its mechanism in BV2 cells. Firstly, the anti-T. gondii effect of rutin in BV2 cells was explored by detecting rutin cytotoxicity, T. gondii inhibition rate and proliferation by CCK8 and indirect fluorescence staining, etc. Subsequently, the cells were divided into four groups: normal group (Normal), T. gondii infected control group (T. gondii), and T. gondii infected groups with low-dose rutin (Rut 50) and T. gondii infected groups with high-dose Rutin (rut 100). Then T. gondii infection and rutin treatment experiments were performed, and the levels of antioxidant enzymes SOD, GSH and lipid oxidation product MDA, the levels of inflammatory factors TNF-α, IL-6 and IL-1β in the supernatant were detected by ELISA methods. The expression of key proteins in PI3K/AKT/Nrf2/HO-1, TLR4/NF-κB and P2X7R/NLRP3 signaling pathways in BV2 cells were detected by Western blot. The results showed that 50 and 100 μg·mL^－1 of rutin had a significant anti-T. gondii effect in BV2 cells, as the T. gondii infection rate, invasion ability and proliferation were significantly inhibited (P < 0.05). Rutin also significantly increased the SOD and GSH activities and decreased the MDA content (P < 0.05), and decreased TNF-α, IL-6 and IL-1β levels in the supernatant (P < 0.05). And it also significantly up-regulated the expression of key proteins in the antioxidant pathway PI3K/AKT/Nrf2/HO-1, and down-regulated the inflammatory pathway TLR4/NF-κB and P2X7R/NLRP3 (P < 0.05). These results indicated that rutin has a significant anti-T. gondii effect in BV2 cells in vitro, which may be related to its ability to enhance cellular antioxidant capacity through activation of the PI3K/AKT/Nrf2/HO-1 pathway, as well as inhibit the TLR4/NF-κB and P2X7R/NLRP3 pathways to attenuate inflammatory responses. These findings may provide some theoretical references for further research on the anti-T. gondii effect of rutin in vivo, as well as its protective effect in T. gondii-induced brain damage. It may also provide some theoretical basis for the development of rutin as a potential therapeutic agent for the treatment of toxoplasmosis in humans and animals.

Key words: rutin, anti-T. gondii effect, BV2 cells, antioxidant, anti-inflammatory, PI3K/AKT/Nrf2/HO-1, TLR4/NF-κB, P2X7R/NLRP3

中图分类号:

S859.7

韩成全, 刘婧陶, 于淼, 关立增, 徐璐, 王悦尚. 芦丁在BV2细胞中抗弓形虫的作用及机制分析[J]. 畜牧兽医学报, 2024, 55(7): 3119-3131.

Chengquan HAN, Jingtao LIU, Miao YU, Lizeng GUAN, Lu XU, Yueshang WANG. Study on the Anti-Toxoplasma gondii Effect of Rutin in BV2 Cells and Its Mechanism[J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(7): 3119-3131.

图/表 9

图 1

图 2

图 3

图 4

图 5

图 6

图 7

图 8

图 9

参考文献 53

1	FERGUSON D J P . Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore[J]. Mem Inst Oswaldo Cruz, 2009, 104 (2): 133- 148. doi: 10.1590/S0074-02762009000200003
2	BAKHRAIBAH A O . Warm-blooded animal toxoplasmosis and its connection to COVID-19:A review[J]. Microb Biosyst, 2022, 7 (1): 18- 26. doi: 10.21608/mb.2022.247310
3	NAYERI T , SARVI S , DARYANI A . Toxoplasma gondii in mollusks and cold-blooded animals: a systematic review[J]. Parasitology, 2021, 148 (8): 895- 903.
4	FRENKEL J K , QUINTERO-NUNEZ R , HASSANEIN R S , et al. Transmission of Toxoplasma gondii in Panama City, Panama: a five-year prospective cohort study of children, cats, rodents, birds, and soil[J]. Am J Trop Med Hyg, 1995, 53 (5): 458- 468.
5	DUBEY J P . The History of Toxoplasma gondii—the First 100 years[J]. J Eukaryot Microbiol, 2008, 55 (6): 467- 475. doi: 10.1111/j.1550-7408.2008.00345.x
6	TENTER A M , HECKEROTH A R , WEISS L M . Toxoplasma gondii: from animals to humans[J]. Int J Parasitol, 2000, 30 (12-13): 1217- 1258. doi: 10.1016/S0020-7519(00)00124-7
7	DUBEY J P , JONES J L . Toxoplasma gondii infection in humans and animals in the United States[J]. Int J Parasitol, 2008, 38 (11): 1257- 1278.
8	HILL D E , HALEY C , WAGNER B , et al. Seroprevalence of and risk factors for Toxoplasma gondii in the US swine herd using sera collected during the National Animal Health Monitoring Survey (Swine 2006)[J]. Zoonoses Public Health, 2010, 57 (1): 53- 59. doi: 10.1111/j.1863-2378.2009.01275.x
9	LINDSAY D S , SMITH P C , HOERR F J , et al. Prevalence of encysted Toxoplasma gondii in raptors from Alabama[J]. J Parasitol, 1993, 79 (6): 870- 873. doi: 10.2307/3283724
10	DUBEY J P , GAMBLE H R , HILL D , et al. High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in massachusetts[J]. J Parasitol, 2002, 88 (6): 1234- 1238. doi: 10.1645/0022-3395(2002)088[1234:HPOVTG]2.0.CO;2
11	HILL D E , DUBEY J P . Toxoplasma gondii prevalence in farm animals in the United States[J]. Int J Parasitol, 2013, 43 (2): 107- 113. doi: 10.1016/j.ijpara.2012.09.012
12	DUBEY J P , RAJENDRAN C , FERREIRA L R , et al. High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA[J]. Int J Parasitol, 2011, 41 (8): 827- 833.
13	WANG Z D , LIU H H , MA Z X , et al. Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis[J]. Front Microbiol, 2017, 8, 389.
14	BALIU C , SANCLEMENTE G , CARDONA M , et al. Toxoplasmic encephalitis associated with meningitis in a heart transplant recipient[J]. Transpl Infect Dis, 2014, 16 (4): 631- 633.
15	PEKOVA L , PARUSHEVA P , MITEV M , et al. A rare case of an HIV-seronegative patient with Toxoplasma gondii meningoencephalitis[J]. IDCases, 2021, 26, e01271.
16	BUXTON D , FINLAYSON J . Experimental infection of pregnant sheep with Toxoplasma gondii: pathological and immunological observations on the placenta and foetus[J]. J Comp Pathol, 1986, 96 (3): 319- 333.
17	NÚÑEZ E R , AYALA T B , CERVANTES G I V , et al. Pregestational exposure to T.gondii produces maternal antibodies that recognize fetal brain mimotopes and induces neurochemical and behavioral dysfunction in the offspring[J]. Cells, 2022, 11 (23): 3819.
18	陈梁元, 莫娇, 曾庆源, 等. 抗弓形虫药物研究进展[J]. 中国人兽共患病学报, 2023, 39 (2): 161- 171.
	CHEN L Y , MO J , ZENG Q Y , et al. Research progress in anti-Toxoplasma gondii drugs[J]. Chinese Journal of Zoonoses, 2023, 39 (2): 161- 171.
19	张吉丽, 司鸿飞, 李冰, 等. 抗弓形虫药物应用现状与研究进展[J]. 中国兽医科学, 2019, 49 (8): 1054- 1060.
	ZHANG J L , SI H F , LI B , et al. Current situation and research progress of anti-Toxoplasma drugs[J]. Chinese Veterinary Science, 2019, 49 (8): 1054- 1060.
20	ALDAY H , DOGGETT J . Drugs in development for toxoplasmosis: advances, challenges, and current status[J]. Drug Des Dev Ther, 2017, 11, 273- 293.
21	WORMSER G P , TANOWITZ H B , WEISS L M . Toxoplasmosis: a comprehensive clinical guide edited by David H.M. Joynson and Tim G. Wreghitt New York: Cambridge University Press, 2001.410 pp., illustrated.＄100.00(cloth)[J]. Clin Infect Dis, 2002, 34 (12): 1664- 1665.
22	HAN C Q , GUAN L Z , XU L . Protective effect of luteoloside against Toxoplasma gondii-induced liver injury through inhibiting TLR4/NF-κB and P2X7R/NLRP3 and enhancing Nrf2/HO-1 signaling pathway[J]. Parasitol Res, 2023, 122 (6): 1333- 1342.
23	CHEN Q W , DONG K , QIN H X , et al. Direct and indirect inhibition effects of resveratrol against Toxoplasma gondii tachyzoites in vitro[J]. Antimicrob Agents Chemother, 2019, 63 (3): e01233- 18.
24	XU L , YU Y F , SANG R , et al. Inonotus obliquus polysaccharide protects against adverse pregnancy caused by Toxoplasma gondii infection through regulating Th17/Treg balance via TLR4/NF-κB pathway[J]. Int J Biol Macromol, 2020, 146, 832- 840.
25	蒲元华, 张德林. 弓形虫入侵宿主机制及免疫学研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30 (6): 480-485, 490.
	PU Y H , ZHANG D L . Research progress on invasion mechanism and immunology of Toxoplasma gondii[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2012, 30 (6): 480-485, 490.
26	SHEN X Y , LU J M , LU Y N , et al. Coixol ameliorates Toxoplasma gondii infection-induced lung injury by interfering with T.gondii HSP70/TLR4/NF-κB signaling pathway[J]. Int Immunopharmacol, 2023, 118, 110031.
27	DE OLIVEIRA M R , FERREIRA G C , SCHUCK P F , et al. Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells[J]. Chem Biol Interact, 2015, 242, 396- 406.
28	DING X , GE B J , WANG M , et al. Inonotus obliquus polysaccharide ameliorates impaired reproductive function caused by Toxoplasma gondii infection in male mice via regulating Nrf2-PI3K/AKT pathway[J]. Int J Biol Macromol, 2020, 151, 449- 458.
29	LUCCI N , MAZZAFERA P . Rutin synthase in fava d'anta: purification and influence of stressors[J]. Can J Plant Sci, 2009, 89 (5): 895- 902.
30	YONG D O C , SAKER S R , CHELLAPPAN D K , et al. Molecular and immunological mechanisms underlying the various pharmacological properties of the potent bioflavonoid, rutin[J]. Endocr Metab Immune, 2020, 20 (10): 1590- 1596.
31	SHARMA S , ALI A , ALI J , et al. Rutin: therapeutic potential and recent advances in drug delivery[J]. Expert Opin Inv Drugs, 2013, 22 (8): 1063- 1079.
32	THOMAS N S , GEORGE K , ARIVALAGAN S , et al. The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects[J]. Eur J Nutr, 2017, 56 (7): 2353- 2366.
33	刘慧娟, 庄苏, 张佳琦, 等. 日粮添加不同水平芦丁对热应激小鼠睾丸组织的影响[J]. 畜牧兽医学报, 2022, 53 (8): 2586- 2597. doi: 10.11843/j.issn.0366-6964.2022.08.017
	LIU H J , ZHUANG S , ZHANG J Q , et al. Effects of dietary supplementation of different levels of Rutin on testicular tissue in mice under heat stress[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53 (8): 2586- 2597. doi: 10.11843/j.issn.0366-6964.2022.08.017
34	SONG H L , ZHANG X , WANG W Z , et al. Neuroprotective mechanisms of rutin for spinal cord injury through anti-oxidation and anti-inflammation and inhibition of p38 mitogen activated protein kinase pathway[J]. Neural Regen Res, 2018, 13 (1): 128.
35	MUHIE Y , KEBKES S . Toxoplasmosis: emerging and re-emerging zoonosis[J]. Afr J Microbiol Res, 2014, 3, 1- 11.
36	MAMAGHANI A J , FATHOLLAHI A , ARAB-MAZAR Z , et al. Toxoplasma gondii vaccine candidates: a concise review[J]. Ir J Med Sci, 2023, 192 (1): 231- 261.
37	CHU K B , QUAN F S . Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development[J]. Vaccines(Basel), 2021, 9 (5): 413.
38	ARDABILI S , KOHL J , GVL G , et al. What obstetricians should be aware of: serious side effects of antibiotic toxoplasmosis treatment in pregnancy[J]. BMJ Case Rep, 2021, 14 (3): e240809.
39	DE SOUSA K M N , VIANA A C C , DA SILVA CAIRES S D F F , et al. Profile of adverse events in toxoplasmosis drug therapy: a review[J]. Res Soc Dev, 2021, 10 (13): e505101321339.
40	RAY P D , HUANG B W , TSUJI Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling[J]. Cell Signal, 2012, 24 (5): 981- 990.
41	BETTERIDGE D J . What is oxidative stress?[J]. Metabolism, 2000, 49 (2 Suppl 1): 3- 8.
42	SZEWCZYK-GOLEC K , PAWŁOWSKA M , WESOŁOWSKI R , et al. Oxidative stress as a possible target in the treatment of toxoplasmosis: Perspectives and ambiguities[J]. Int J Mol Sci, 2021, 22 (11): 5705.
43	KARAMAN U , CELIK T , KIRAN T R , et al. Malondialdehyde, glutathione, and nitric oxide levels in Toxoplasma gondii seropositive patients[J]. Korean J Parasitol, 2008, 46 (4): 293.
44	DING K N , LU M H , GUO Y N , et al. Resveratrol relieves chronic heat stress-induced liver oxidative damage in broilers by activating the Nrf2-Keap1 signaling pathway[J]. Ecotoxicol Environ Saf, 2023, 249, 114411.
45	ZHANG K Z . Integration of ER stress, oxidative stress and the inflammatory response in health and disease[J]. Int J Clin Exp Med, 2010, 3 (1): 33- 40.
46	SANG R , SUN F L , ZHOU H Y , et al. Immunomodulatory effects of Inonotus obliquus polysaccharide on splenic lymphocytes infected with Toxoplasma gondii via NF-κB and MAPKs pathways[J]. Immunopharm Immunot, 2022, 44 (1): 129- 138.
47	GOV L , SCHNEIDER C A , LIMA T S , et al. NLRP3 and potassium efflux drive rapid IL-1β release from primary human monocytes during Toxoplasma gondii infection[J]. J Immunol, 2017, 199 (8): 2855- 2864.
48	HOU L S , CUI Z Y , SUN P , et al. Rutin mitigates hepatic fibrogenesis and inflammation through targeting TLR4 and P2X7 receptor signaling pathway in vitro and in situ[J]. J Funct Foods, 2020, 64, 103700.
49	WILLIAMS D H , JEFFERY L J , MURRAY E J . Aurothioglucose inhibits induced NF-kB and AP-1 activity by acting as an IL-1 functional antagonist[J]. Biochim Biophys Acta Mol Basis Dis, 1992, 1180 (1): 9- 14.
50	KIM E J , KIM Y J , LEE H I , et al. NRF2 knockdown resensitizes 5-fluorouracil-resistant pancreatic cancer cells by suppressing HO-1 and ABCG2 expression[J]. Int J Mol Sci, 2020, 21 (13): 4646.
51	JAIN V , YOGAVEL M , OSHIMA Y , et al. Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis[J]. Structure, 2015, 23 (5): 819- 829.
52	CHOI K M , GANG J , YUN J . Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine[J]. Int J Antimicrob Agents, 2008, 32 (4): 360- 362.
53	SI H F , XU C Y , ZHANG J L , et al. Licochalcone A: an effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo[J]. Int J Parasitol Drugs Drug Resist, 2018, 8 (2): 238- 245.

[1]	杜红旭, 苏利娟, 何政科, 谭晓燕, 张旭, 马琪, 曹立亭, 陈红伟, 甘玲. 五味子多糖纳米硒的体外抗氧化和肠道菌群调节作用研究[J]. 畜牧兽医学报, 2024, 55(7): 3234-3245.
[2]	刘彬, 刘彦, 郑琛, 冯涛. 氨基葡萄糖对断奶仔猪生长性能、抗氧化能力及免疫功能的影响[J]. 畜牧兽医学报, 2024, 55(7): 3246-3254.
[3]	苏依曼, 叶嘉莉, 邱文粤, 章心婷, 庞晓玥, 王荣梅, 唐兆新, 苏荣胜. 积雪草酸通过抑制HMGB1/TLR4/NF-κB通路减轻脂多糖诱导肉鸡肾细胞焦亡[J]. 畜牧兽医学报, 2024, 55(4): 1777-1786.
[4]	姜丽君, 宗云鹤, 李云雷, 陈继兰, 耿照玉, 孙研研, 金四华. 抗氧化剂在家禽精液储存中的应用研究进展[J]. 畜牧兽医学报, 2024, 55(3): 913-923.
[5]	片慧芳, 杜旭彬, 李妍, 张雨辰, 何惠, 虞德兵. 甜菜碱对产蛋后期蛋鸡生产性能、蛋品质和抗氧化能力的影响[J]. 畜牧兽医学报, 2024, 55(3): 1085-1094.
[6]	王栋, 柳可欣, 何炎峻, 邓守翔, 刘云, 马卫明. 饲粮中添加腐殖酸钠对鼠伤寒沙门菌感染肉鸡肝组织炎症和抗氧化能力的影响[J]. 畜牧兽医学报, 2024, 55(2): 629-639.
[7]	韩坤良, 兰伟, 胡新, 崔亚东, 孔祥峰. 复方中药超微粉对蛋鸡抗氧化性能及相关基因表达的影响[J]. 畜牧兽医学报, 2023, 54(9): 3784-3792.
[8]	陈喜宏, 路桂聪, 王浩磊, 苟少校, 玉永雄, 林涛, 蒋曹德. 利用牛乳腺细胞和小鼠乳腺组织分析异绿原酸C通过NF-κB信号通路对乳腺炎症反应的抑制效应[J]. 畜牧兽医学报, 2023, 54(9): 3931-3940.
[9]	熊程坤, 张道亮, 杨悦, 丁红研, 赵杰, 李玉, 王希春, 冯士彬, 赵畅, 汤继顺, 吴金节. 芦丁对围产期湖羊瘤胃发酵、瘤胃菌群结构及抗氧化性能的影响[J]. 畜牧兽医学报, 2023, 54(7): 2898-2909.
[10]	赵栋皓, 原梦, 马凯腾, 段卓, 祝一鑫, 唐芳, 韩克光, 霍乃蕊. 羊骨胶原肽对镉的螯合作用及对镉致鸡肝损伤的干预作用[J]. 畜牧兽医学报, 2023, 54(6): 2641-2652.
[11]	杨子辉, 董朕, 伍蕙岚, 谭斌, 曾建国. 基于网络药理学分析蒲公英抗氧化功能的物质基础与作用机制[J]. 畜牧兽医学报, 2023, 54(5): 2170-2185.
[12]	刘燕坤, 罗润波, 林焱, 朱伟云. 噬菌体鸡尾酒对断奶仔猪生长性能、血液参数和粪样菌群的影响[J]. 畜牧兽医学报, 2023, 54(4): 1555-1567.
[13]	刘慧娟, 王超, 周斌斌, 张佳琦, 王恬, 庄苏. 饲粮中添加芦丁对肉鸡回肠形态、免疫、抗氧化及屏障功能的影响[J]. 畜牧兽医学报, 2023, 54(2): 630-641.
[14]	徐自强, 刘金松, 孙耀威, 史永浩, 吴艳萍, 张瑞强. 月桂酸对肉鸡屠宰性能、肌肉品质和抗氧化功能的影响[J]. 畜牧兽医学报, 2023, 54(11): 4691-4701.
[15]	苏丹, 文晓宾, 马腾, 钟儒清, 王阳, 陈亮. 羟基酪醇对肉仔鸡生长性能、抗氧化能力和肠道炎性因子的影响[J]. 畜牧兽医学报, 2023, 54(11): 4851-4859.

芦丁在BV2细胞中抗弓形虫的作用及机制分析

Study on the Anti-Toxoplasma gondii Effect of Rutin in BV2 Cells and Its Mechanism

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 9

参考文献 53

相关文章 15

编辑推荐

Metrics

本文评价